TNFRSF4 and conjunctivitis: Increased eosinophilic factors in tears, an infestation of Demodex mites, and the increased activity of OX40 ligands have been proposed to explain the specific interplay between dupilumab and conjunctivitis in patients with AD; however, these hypotheses have yet to be proven [42,43,44].